Tower Research Capital (TRC)’s Revelation Biosciences REVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61K | Buy |
1,159
+478
| +70% | +$1.08K | ﹤0.01% | 4624 |
|
|
2025
Q1 | $5.37K | Buy |
681
+628
| +1,185% | +$4.96K | ﹤0.01% | 4127 |
|
|
2024
Q4 | $1.17K | Hold |
53
| – | – | ﹤0.01% | 5076 |
|
|
2024
Q3 | $2.16K | Sell |
53
-51
| -49% | -$2.08K | ﹤0.01% | 5040 |
|
|
2024
Q2 | $9.56K | Buy |
104
+39
| +60% | +$3.59K | ﹤0.01% | 4228 |
|
|
2024
Q1 | $8.54K | Buy |
65
+63
| +3,150% | +$8.28K | ﹤0.01% | 4004 |
|
|
2023
Q4 | $1.14K | Hold |
2
| – | – | ﹤0.01% | 5422 |
|
|
2023
Q3 | $1.59K | Buy |
2
+1
| +100% | +$793 | ﹤0.01% | 5302 |
|
|
2023
Q2 | $1.04K | Buy |
+1
| New | +$1.04K | ﹤0.01% | 5461 |
|
|
2023
Q1 | – | Hold |
0
| – | -$2K | – | 6199 |
|
|
2022
Q4 | – | Hold |
0
| – | -$2K | – | 5413 |
|
|
2022
Q3 | – | Hold |
0
| – | -$6K | – | 5604 |
|
|
2022
Q2 | – | Hold |
0
| – | -$4K | – | 4947 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5242 |
|
|
2021
Q3 | – | Hold |
0
| – | -$1K | – | 6099 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5242 |
|